Myriad Genetics Ownership | Who Owns Myriad Genetics?


OverviewForecastRevenueFinancialsChartTranscripts

Myriad Genetics Ownership Summary


Myriad Genetics is owned by 18.73% institutional investors, 2.90% insiders, and 78.37% retail investors. Blackrock is the largest institutional shareholder, holding 18.54% of MYGN shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 5.89% of its assets in Myriad Genetics shares.

MYGN Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockMyriad Genetics18.73%2.90%78.37%
SectorHealthcare Stocks 42.54%10.83%46.63%
IndustryDiagnostics & Research Stocks46.31%10.49%43.20%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock15.15M18.54%$370.59M
Blackrock funding, inc. /de14.88M16.09%$107.58M
Vanguard group7.88M8.52%$56.99M
State street4.98M5.38%$35.98M
Glenview capital management4.59M4.96%$33.17M
Millennium management4.35M4.78%$59.57M
Morgan stanley3.62M3.91%$26.15M
Bank of america corp /de/2.71M3.31%$66.18M
Geode capital management2.23M2.41%$16.09M
Goldman sachs group2.15M2.33%$15.56M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Amh equity400.00K3.60%$2.89M
Camber capital management lp2.00M1.00%$10.62M
Glenview capital management4.59M0.74%$33.17M
Anson funds management lp504.38K0.33%$3.65M
Vestal point capital, lp600.00K0.20%$4.34M
Algert global913.07K0.11%$6.60M
Aimz investment advisors39.19K0.09%$283.31K
Inspire investing79.69K0.06%$576.13K
Vise11.65K0.05%$284.98K
Dynamic technology lab private40.41K0.05%$292.00M

Top Buyers

HolderShares% AssetsChange
Assenagon asset management1.30M0.01%979.13K
Algert global913.07K0.11%913.07K
Goldman sachs group2.15M0.00%868.33K
Royce & associates lp670.00K0.05%670.00K
D. e. shaw1.82M0.02%668.43K

Top Sellers

HolderShares% AssetsChange
Wellington management group llp---4.59M
Earnest partners---3.98M
Sei investments---2.42M
Artisan partners limited partnership---2.28M
Loomis sayles & co l p---2.19M

New Positions

HolderShares% AssetsChangeValue
Royce & associates lp670.00K0.05%670.00K$4.84M
Vestal point capital, lp600.00K0.20%600.00K$4.34M
Weiss asset management lp130.34K0.01%130.34K$942.38K
Los angeles capital management81.40K0.00%81.40K$588.49K
Martingale asset management l p74.02K0.01%74.02K$535.19M

Sold Out

HolderChange
Cnb bank-1.00
Sjs investment consulting-2.00
Jfs wealth advisors-3.00
Global financial private client-3.00
Mendota financial group-3.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202579-62.74%17,328,183-77.55%180.27%39-69.29%25-52.83%
Jun 30, 2025218-5.63%90,330,011-3.80%970.92%1308.33%52-32.47%
Mar 31, 20252303.60%93,858,1281.60%1031.00%119-1.65%774.05%
Dec 31, 2024205-17.00%86,534,887-4.62%950.77%111-15.91%70-1.41%
Sep 30, 20242457.46%90,699,410-1.73%1100.87%1313.15%7112.70%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
iShares Core S&P Small-Cap ETF5.48M5.89%-
Vanguard Explorer Inv3.10M3.40%-190.91K
Vanguard US Total Market Shares ETF2.70M2.96%2.75K
Vanguard Total Stock Mkt Idx Inv2.66M2.85%-58.92K
iShares Russell 2000 ETF2.19M2.35%-
Artisan Non-U.S. Small-Mid Growth Comp1.56M1.70%-281.57K
Artisan International Small-Mid Investor1.56M1.70%-281.57K
EARNEST Partners Smid Cap Core Founders1.40M1.52%-970.66K
SPDR® S&P Biotech ETF1.38M1.48%3.08K
Vanguard Small Cap Index1.06M1.14%-7.19K

Recent Insider Transactions


DateNameRoleActivityValue
Oct 11, 2024DIAZ PAUL J President and CEOSell$343.95K
Sep 11, 2024DIAZ PAUL J President and CEOSell$400.80K
Sep 11, 2024Muzzey Dale Chief Scientific OfficerSell$54.96K
Sep 09, 2024Dreismann Heinrich-Sell$270.52K
Sep 03, 2024Reitan Colleen F-Sell$1.29M

Insider Transactions Trends


DateBuySell
2025 Q4--
2025 Q3--
2025 Q2--
2025 Q1--
2024 Q4-1

MYGN Ownership FAQ


Who Owns Myriad Genetics?

Myriad Genetics shareholders are primarily institutional investors at 18.73%, followed by 2.90% insiders and 78.37% retail investors. The average institutional ownership in Myriad Genetics's industry, Diagnostics & Research Stocks, is 46.31%, which Myriad Genetics falls below.

Who owns the most shares of Myriad Genetics?

Myriad Genetics’s largest shareholders are Blackrock (15.15M shares, 18.54%), Blackrock funding, inc. /de (14.88M shares, 16.09%), and Vanguard group (7.88M shares, 8.52%). Together, they hold 43.14% of Myriad Genetics’s total shares outstanding.

Does Blackrock own Myriad Genetics?

Yes, BlackRock owns 18.54% of Myriad Genetics, totaling 15.15M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 370.59M$. In the last quarter, BlackRock increased its holdings by 271.49K shares, a 1.82% change.

Who is Myriad Genetics’s biggest shareholder by percentage of total assets invested?

Amh equity is Myriad Genetics’s biggest shareholder by percentage of total assets invested, with 3.60% of its assets in 400K Myriad Genetics shares, valued at 2.89M$.

Who is the top mutual fund holder of Myriad Genetics shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of Myriad Genetics shares, with 5.89% of its total shares outstanding invested in 5.48M Myriad Genetics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools